1α,25-Dihydroxyvitamin D3 activates T cells of tumor bearers through protein phosphatase 2A

Cancer Immunology Immunotherapy

Volumn 44, Issue 2, 1997, Pages 97-102

  Wiers, Kristina M ^a   Lozano, Yvonne ^a   Messingham, Kelly A Nordyke ^b   Metz, Raymond J ^b   Young, M Rita I ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

protein phosphatase; T cell; tumor; vitamin D3

Indexed keywords

CALCITRIOL; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; CD3 ANTIGEN; GAMMA INTERFERON; LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE ACTIVATION; METABOLISM; SECRETION; SPLEEN; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD3; CALCITRIOL; CARCINOMA, LEWIS LUNG; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERFERON TYPE II; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PHOSPHOPROTEIN PHOSPHATASE; RECEPTORS, ANTIGEN, T-CELL; SPLEEN; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0030609863     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050361     Document Type: Article

References (29)

1. Alexander JP, Kudoh S, Melsop KA, Hamilton TA, Edinger MG, Tubbs RR, Sica D, Tuason L, Klein E, Budowski RM, Finke JH (1993) T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res 53: 1380
2. Alleva DG, Burger CJ, Elgert KD (1994) Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-γ. Scand J Immunol 39: 31
3. Alpdogan O, Ozgun S, Lawrence R, Ozener C, Akoglu E, Akoglu T (1995) The effect of 1,25 dihydroxyvitamin D3 on lymphocyte transformation in patients with chronic renal failure. Intern Med 34: 240
4. Aoe T, Okamoto Y, Saito T (1995) Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J Exp Med 181: 1881
5. Cohen P (1991) Classification of protein-serine/threonine phosphatases: identification and quantitation in cell extracts. Methods Enzymol 201: 389
6. Denis M (1991) Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin Exp Immunol 84: 200
7. Dobrowsky RT, Kamibayashi G, Mumby MC, Hannun YA (1993) Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 268: 15523
8. Favre B, Zolnierowicz S, Turowski P, Hemmings BA (1994) The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. J Biol Chem 269: 16311
9. Hernandez-Frontera E, McMurray DN (1993) Dietary vitamin D affects cell-mediated hypersensitivity but not resistance to experimental pulmonary tuberculosis in guinea pigs. Infect Immun 61: 2116
10. Higashimoto Y, Ohata M, Iwamoto Y, Fujimoto H, Uetani K, Suruda T, Nakamura Y, Nakai S, Funasako M (1995) Stimulatory effect of 1α,25-dihydroxyvitamin D3 on mouse alveolar macrophage tumor necrosis factor-a production in vitro: involvement of protein kinase C and Ca2+/calmodulin-dependent kinase. Respiration 62: 89
11. Kragballe K, Dam TN, Hansen ER, Baadsgaard O, Gronhoj Larsen F, Sondergaard J, Axelsen MB (1994) Efficacy and safety of the 20-epi-vitamin D3 analogue KH 1060 in the topical therapy of psoriasis: results of a dose-ranging study. Acta Derm Venereol (Stockh) 74: 398
12. Lacey DL, Erdmann JM, Tan HL (1993) 1,25-Dihydroxyvitamin D3 increases type 1 interleukin-1 receptor expression in a murine T cell line. J Cell Biochem 52: 159
13. Law B, Rossie S (1995) The dimeric and catalytic subunit forms of protein phosphatase 2A from rat brain are stimulated by C2-ceramide. J Biol Chem 270: 12808
14. Lemire JM (1995) Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 53: 599
15. Manolagas SC, Yu XP, Girasole G, Bellido T (1993) Vitamin D and the hematolymphopoietic tissue: a 1994 update. Semin Nephrol 14: 129
16. Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R (1992) 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 41: 1491
17. Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC (1992) Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258: 1795
18. + cells. Autoimmunity 14: 37
19. 3. Vet Immunol Immunopathol 38: 75
20. Okazaki T, Bell RM, Hannun YA (1989) Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem 264: 19076
21. 3-induced HL-60 cell differentiation. J Biol Chem 265: 15823
22. Prechel MM, Lozano Y, Wright MA, Ihm J, Young MRI (1995) Ineffective immune enhancement by IL-12 in tumor-bearing mice whose immune depression is mediated by suppressive granulocyte-macrophage progenitor cells. Cancer Lett 92: 235
23. 3 treatments to block induction of immune suppressive granulocyte-macrophage progenitor cells. Cancer Iminunol Immunother 42: 213
24. 3. Blood 80: 2811
25. Richards FM, Milner J, Metcalfe S (1992) Inhibition of the serine/threonine protein phosphatases PP-1 and PP-2A in lymphoctes: effect on mRNA levels for interleukin-2, IL-2Rα, krox-24, p53, hsc70 and cyclophilin. Immunology 76: 642
26. Yang S, Smith C, Prahl JM, Luo X, DeLuca HF (1993) Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys 303: 98
27. Yoshino I, Yano T, Murata M, Ishida T, Sugimachi K, Kimura G (1992) Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor. Cancer Res 52: 775
28. Young MRI, Wright MA (1992) Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: interteron-γ plus tumor necrosis factor-α synergistically reduce immune suppressor and tumor growth-promoting activities of hone marrow cells, and diminish tumor recurrence and metastasis. Cancer Res 52: 6335
29. Young MRI, Lozano Y, Ihm J, Wright MA, Prechel MM (1996) Vitamin D3 treatment of tumor bearers can stimulate immune competence and reduce tumor growth when treatment coincides with a heightened presence of natural suppressor cells. Cancer Lett 104: 153